Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Edit Your Profile
Cumulative dose of motexafin gadolinium (MGd) and survival in newly diagnosed glioblastoma multiforme (GBM)
Conference
Mehta, M, Ford, JM, Suh, J
et al
. (2004). Cumulative dose of motexafin gadolinium (MGd) and survival in newly diagnosed glioblastoma multiforme (GBM) .
NEURO-ONCOLOGY,
6(4), 378-378.
Share this citation
Twitter
Email
Mehta, M, Ford, JM, Suh, J
et al
. (2004). Cumulative dose of motexafin gadolinium (MGd) and survival in newly diagnosed glioblastoma multiforme (GBM) .
NEURO-ONCOLOGY,
6(4), 378-378.
Copy Citation
Share
Industry Collaboration
Overview
Research
Location
Additional Document Info
View All
Overview
cited authors
Mehta, M; Ford, JM; Suh, J; Phan, S
sustainable development goals
SDG 03: Good Health and Well-being
authors
Mehta, Minesh
date/time interval
November 18, 2004 -
publication date
October 1, 2004
webpage
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224332400287&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=e451fd656366bf1ec5554941920a9ccb
published in
NEURO-ONCOLOGY
Journal
Research
keywords
Clinical Neurology
Life Sciences & Biomedicine
Neurosciences & Neurology
Oncology
Science & Technology
Location
Location
Toronto, CANADA
Additional Document Info
Conference
9th Annual Meeting of the Society-for-Neuro-Oncology
publisher
DUKE UNIV PRESS
start page
378
end page
378
volume
6
issue
4